High VLA-4 expression is associated with adverse outcome and distinct gene expression changes in childhood B-cell precursor acute lymphoblastic leukemia at first relapse

Documenti analoghi

• NOTCH1 mutation, TP53 alteration and myeloid antigen expression predict outcome heterogeneity in children with first relapse of T-cell acute lymphoblastic leukemia
  di: Hof, Jana, et al.
  Pubblicazione: (2017)
• Subclonal NT5C2 mutations are associated with poor outcomes after relapse of pediatric acute lymphoblastic leukemia
  di: Barz, Malwine J., et al.
  Pubblicazione: (2020)
• Copy number genome alterations are associated with treatment response and outcome in relapsed childhood ETV6/RUNX1-positive acute lymphoblastic leukemia
  di: Bokemeyer, Almut, et al.
  Pubblicazione: (2014)
• Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition
  di: Irving, Julie, et al.
  Pubblicazione: (2014)
• Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia
  di: Karawajew, Leonid, et al.
  Pubblicazione: (2015)